New integrated framework advances precision surgery for liver cancer
Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally. Despite…
Combination therapy overcomes ferroptosis resistance in β-catenin-mutant hepatocellular carcinoma
Background and aims The aberrant activation of the mTOR pathway and its crosstalk with other signaling cascades represent…
Daily tomatoes lowered a key marker of liver fat in MASLD trial
A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
Integrating gene signatures and multi omics improves liver cancer treatment
Hepatocellular carcinoma (HCC) remains highly fatal due to late diagnosis and scarce early biomarkers. Multi‑omics and liquid biopsy…
New roadmap links liver cancer biology to immunotherapy and precision medicine
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona…
Machine learning model predicts liver cancer risk with high accuracy
Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test…
Researchers develop new score to predict the risk of liver cancer
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed…
University of Missouri launches first on-campus radiopharmaceutical clinical trial
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Coffee protects the liver by blocking inflammation and scarring, review finds
Scientists reveal how your daily cup of coffee may guard against liver disease, connecting population trends with the…